These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22049548)

  • 1. Retraction notice to "Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors" [Eur. J. Med. Chem. (2010) 909-914].
    Eur J Med Chem; 2011 Oct; 46(10):5225. PubMed ID: 22049548
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitors.
    Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Taliani S; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
    J Med Chem; 2001 Dec; 44(25):4359-69. PubMed ID: 11728182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to “Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen” [Eur. J. Med. Chem. (2010) 3162-3168].
    Eur J Med Chem; 2012 Jan; 47(1):626. PubMed ID: 22355807
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors" [Eur. J. Med. Chem. 92 (2015) 459-470].
    Gomha SM; Abdulla MM; Abou-Seri SM
    Eur J Med Chem; 2016 Oct; 121():939. PubMed ID: 27523643
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of an aldose reductase from pig lens. Comparative studies of an aldehyde reductase from pig lens.
    Branlant G
    Eur J Biochem; 1982 Dec; 129(1):99-104. PubMed ID: 6819141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to “Proton-pumping-ATPase-targeted antifungal activity of cinnamaldehyde based sulfonyl tetrazoles” [Eur. J. Med. Chem. 48 (2012) 363-370].
    Eur J Med Chem; 2012 Nov; 57():483. PubMed ID: 22640886
    [No Abstract]   [Full Text] [Related]  

  • 8. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
    Juskova M; Majekova M; Demopoulos V; Stefek M
    Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and aldose reductase inhibitory activity of triazine derivatives possessing acetic acid group.
    Mavel S; Coudert P; Albuisson E; Duroux E; Bastide P; Couquelet J; Tronche P; Rubat C
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1411-4. PubMed ID: 1394661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].
    Fang B; Lai Y; Yan H; Ma Y; Ni Z; Zhu Q; Zhang J; Ye Y; Wang M; Wang P; Wang Y; Zhang S; Hui M; Wang D; Zhao Y; Li X; Wang K; Liu Z
    Eur J Med Chem; 2024 Mar; 268():116230. PubMed ID: 38368135
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to "Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation" [Eur. J. Med. Chem. 106 (2015) 85-94].
    Januchta W; Serocki M; Dzierzbicka K; Cholewiński G; Skladanowski A
    Eur J Med Chem; 2016 Jun; 116():318-319. PubMed ID: 27177783
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "New desulfured troglitazone derivatives: Improved synthesis and biological evaluation" [Eur. J. Med. Chem. 187 (2020) 111939].
    Dupommier D; Muller C; Comoy C; Mazerbourg S; Bordessa A; Piquard E; Pawlak M; Piquard F; Martin H; De Fays E; Grandemange S; Flament S; Boisbrun M
    Eur J Med Chem; 2020 Dec; 208():112834. PubMed ID: 32966897
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease" [Eur. J. Med. Chem. 265 (2024) 116071].
    Liu Y; Ma C; Li Y; Li M; Cui T; Zhao X; Li Z; Jia H; Wang H; Xiu X; Hu D; Zhang R; Wang N; Liu P; Yang H; Cheng M
    Eur J Med Chem; 2024 Mar; 267():116169. PubMed ID: 38290915
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
    Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
    Eur J Med Chem; 2023 Dec; 261():115753. PubMed ID: 37634992
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
    Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
    Eur J Med Chem; 2022 Jan; 228():114041. PubMed ID: 34902733
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors" [Eur. J. Med. Chem. 180 (2019) 171e190].
    Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
    Eur J Med Chem; 2020 Jan; 186():111899. PubMed ID: 31787358
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and aldose reductase inhibitory activity of pyridazine derivatives possessing acetic acid group.
    Coudert P; Rubat C; Duroux E; Bastide P; Couquelet JD; Tronche P; Albuisson E
    Farmaco; 1992 Jan; 47(1):37-46. PubMed ID: 1616576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612].
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5281. PubMed ID: 17987674
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole.
    Pegklidou K; Koukoulitsa C; Nicolaou I; Demopoulos VJ
    Bioorg Med Chem; 2010 Mar; 18(6):2107-2114. PubMed ID: 20189816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2.
    Malamas MS; Hohman TC
    J Med Chem; 1994 Jun; 37(13):2059-70. PubMed ID: 8027987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.